Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Developed by Eli Lilly, retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors a novel mechanism that distinguishes it from existing licensed weight management medicines
:max_bytes(150000):strip_icc()/GettyImages-2260914806-2616be1382184e17a167d542d97230d7.jpg)
GLP-1 stands for glucagon-like peptide-1, an incretin hormone naturally produced in the gut
You cannot simply convert milligrams from one peptide to another because their receptor binding profiles, potency, and mechanisms are different
The key is pairing GLP-1s with coaching that prioritizes muscle retention, balanced nutrition, and long-term health
US$ 21.17
US$ 25.96
US$ 28.24
:format(jpg)/d2lnr5mha7bycj.cloudfront.net/product-image/file/large_a493d346-7184-4364-8d3b-90369c2908fc.png)
US$ 25.23
US$ 28.75
